Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

@article{Ghouri2010LiverEN,
  title={Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data},
  author={N. Ghouri and D. Preiss and N. Sattar},
  journal={Hepatology},
  year={2010},
  volume={52}
}
  • N. Ghouri, D. Preiss, N. Sattar
  • Published 2010
  • Medicine
  • Hepatology
    • In recent years, a strong link has been established between nonalcoholic fatty liver disease (NAFLD) and the pathogenesis of type 2 diabetes mellitus. The potential role of NAFLD in cardiovascular disease (CVD) has also attracted interest. Published studies have tended to use biochemical and imaging surrogate markers of NAFLD, such as elevated gamma glutamyl transpeptidase (GGT) and alanine aminotransferase (ALT) and fatty liver on ultrasound, when investigating associations with incident CVD… CONTINUE READING
    View on Wiley
    aasldpubs.onlinelibrary.wiley.com
    253 Citations
    Highly Influencial Citations
    4
    Background Citations
    56
    Methods Citations
    3
    Results Citations
    1
    253 Citations
    Citation Type

    Citation Type

    The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
    • 22
    Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis
    • 60
    • PDF
    Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
    • 39
    Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents
    • 61
    • PDF
    Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
    • 2
    • PDF
    Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis
    • 20
    Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population
    • 21
    Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
    • 21
    • PDF
    Fatty liver index, gamma‐glutamyltransferase, and early carotid plaques
    • 103
    • PDF
    Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
    • 425
    • PDF

    References

    SHOWING 1-10 OF 42 REFERENCES
    Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.
    • 451
    Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
    • 341
    • PDF
    Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
    • 264
    Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
    • 94
    Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
    • 520
    • PDF
    Body Fat Distribution, Liver Enzymes, and Risk of Hypertension: Evidence From the Western New York Study
    • 91
    Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
    • 1,255
    Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women’s Heart and Health Study and Meta-Analysis
    • 245
    • PDF
    Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.
    • 287
    • PDF
    Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
    • 276